GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives ...

Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital ...

Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first participant ...

Minghui has reported positive topline outcomes from the Phase III trial of MH004 for treating mild to moderate atopic ...

Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...

The Phase III trial of AXS-12 showed results over placebo as the company looks towards a new drug application for its ...

The Phase I trial of the combination therapy saw a an approximate 66% rate of near-complete remission in its cohort of breast ...

MSD has reported that the Phase III ZENITH trial of WINREVAIR for pulmonary arterial hypertension met its primary endpoint.

The announcement means the company will be pulling the plug on the CardinALS trial after its ALS drug failed to halt disease ...

AstraZeneca has reported positive results from a Phase III trial that evaluated Truqap combined with abiraterone and ADT for ...

Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as ...